C. Sun

发表

A comparison of C/B ratios from studies using receiver operating characteristic curve analysis.

R. Richards-Kortum, M. Follen, S. Cantor, 1999, Journal of clinical epidemiology.

Communication of BRCA1 and BRCA2 genetic test results to health care providers following genetic testing at a tertiary care center

B. Arun, K. Lu, S. Peterson, 2011, Familial Cancer.

Is hereditary site-specific ovarian cancer a distinct genetic condition?

W. Foulkes, P. Tonin, S. Narod, 1998, American journal of medical genetics.

Expression of HER-2/neu, epidermal growth factor receptor, vascular endothelial growth factor, cyclooxygenase-2, estrogen receptor, and progesterone receptor in small cell and large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathologic and prognostic study

M. Deavers, P. Ramirez, Charlotte C. Sun, 2004, International Journal of Gynecologic Cancer.

M. Deavers, P. Ramirez, C. Sun, 2004, International Journal of Gynecologic Cancer.

Gynecologic cancer screening and communication with health care providers in women with Lynch syndrome

K. Lu, P. Lynch, S. Peterson, 2014, Clinical genetics.

Ethnic differences in socioeconomic status, diagnosis, treatment, and survival among older women with epithelial ovarian cancer.

Xianglin L. Du, D. Bodurka, S. Fang, 2008, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Prognostic factors in malignant ovarian germ cell tumours (The Surveillance, Epidemiology and End Results experience 1978-2010).

S. Fosså, C. Tropé, H. Weedon-Fekjær, 2014, European journal of cancer.

Phase 1b dose expansion and translational analyses of olaparib in combination with the oral AKT inhibitor capivasertib in recurrent endometrial, triple negative breast, and ovarian, primary peritoneal, or fallopian tube cancer

G. Mills, A. Jazaeri, R. Coleman, 2021, medRxiv.

Ethnic differences in socioeconomic status, diagnosis, treatment, and survival among older women with epithelial ovarian cancer

D. Bodurka, S. Fang, C. Sun, 2007, International Journal of Gynecologic Cancer.

Encouraging responses with bevacizumab in recurrent low-grade serous ovarian cancer.

A. Sood, D. Bodurka, A. Malpica, 2010 .

Atorvastatin does not affect insulin sensitivity and the adiponectin or leptin levels in hyperlipidemic Type 2 diabetes

C. Sun, H. Lam, C. Lu, 2008, Journal of endocrinological investigation.

Evaluating women with ovarian cancer for BRCA 1/2: Missed opportunities

K. Lu, D. Urbauer, S. Westin, 2008 .